Medline Inc.

MDLN Healthcare Medical Instruments & Supplies

Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.

Revenue
+14.1%
Free cash flow
+916.1%
Total debt
−23.7%

Quarter to September 2026, against a year earlier

39.96 0.39 −0.97%
Market cap
$52.3B
P/E
58.4×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
2.25
Beneish M
−2.38
Dividend safety
n/a

Medline Inc. (MDLN) Operating margin

Alert me on Operating margin

Medline Inc.'s operating margin over the twelve months to 30 September 2026 was 29.7%, up 21.9 percentage points from fiscal 2025 (7.78%). That is above the Medical Instruments & Supplies industry median of 1.97% and above the Healthcare sector median of 0.00%.

Operating margin, annual

Embed this chart

Annual newest first

Period Operating margin Change (points)
FY2025 7.78% (0.63)
FY2024 8.41% 3.03
FY2023 5.38% —

Quarterly newest first

Period Operating margin Change (points)
Sep 2026 6.36% 1.22
Jun 2026 5.14% (0.60)
Mar 2026 5.74% (94.26)
Dec 2025 100.0% 90.68
2 more quarters

Operating margin against peers

Company Operating margin
RMD ResMed Inc. compare 33.0%
MDLN Medline Inc. 29.7%
ISRG Intuitive Surgical, Inc. compare 28.4%
WST West Pharmaceutical Services, Inc. compare 23.0%
COO The Cooper Companies, Inc. compare 12.8%
BDX Becton, Dickinson and Company compare 11.1%
ALC Alcon compare 8.73%
SOLV Solventum Corporation compare 0.00%
BAX Baxter International Inc. compare −1.90%
Medical Instruments & Supplies industry median 1.97%
Healthcare sector median 0.00%
Market median 0.00%

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on MDLN